Dashboard
Manage Tickers

ABTABBOTT LABORATORIES

NYSE abbott.com


$ 102.20 $ 0.45 (0.44 %)    

Friday, 31-May-2024 15:59:52 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 454.82 $ -0.84 (-0.19 %)
DIA $ 398.57 $ 6.05 (1.59 %)
SPY $ 530.36 $ 4.76 (0.91 %)
TLT $ 91.26 $ 0.61 (0.68 %)
GLD $ 225.37 $ -1.27 (-0.59 %)
$ 102.19
$ 101.93
$ 0.00 x 0
$ 0.00 x 0
$ 101.40 - $ 102.21
$ 88.80 - $ 121.04
7,658,796
na
178.8B
$ 0.76
$ 31.76
TBD
na
na ($ 0.02)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-02-2024 03-31-2024 10-Q
2 02-16-2024 12-31-2023 10-K
3 11-01-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 02-17-2023 12-31-2022 10-K
7 11-01-2022 09-30-2022 10-Q
8 08-02-2022 06-30-2022 10-Q
9 05-03-2022 03-31-2022 10-Q
10 02-18-2022 12-31-2021 10-K
11 11-03-2021 09-30-2021 10-Q
12 08-04-2021 06-30-2021 10-Q
13 05-05-2021 03-31-2021 10-Q
14 02-19-2021 12-31-2020 10-K
15 11-04-2020 09-30-2020 10-Q
16 07-29-2020 06-30-2020 10-Q
17 04-29-2020 03-31-2020 10-Q
18 02-21-2020 12-31-2019 10-K
19 10-31-2019 09-30-2019 10-Q
20 07-31-2019 06-30-2019 10-Q
21 05-01-2019 03-31-2019 10-Q
22 02-22-2019 12-31-2018 10-K
23 10-31-2018 09-30-2018 10-Q
24 08-01-2018 06-30-2018 10-Q
25 05-02-2018 03-31-2018 10-Q
26 02-16-2018 12-31-2017 10-K
27 11-02-2017 09-30-2017 10-Q
28 08-02-2017 06-30-2017 10-Q
29 05-03-2017 03-31-2017 10-Q
30 02-17-2017 12-31-2016 10-K
31 11-03-2016 09-30-2016 10-Q
32 08-03-2016 06-30-2016 10-Q
33 05-04-2016 03-31-2016 10-Q
34 02-19-2016 12-31-2015 10-K
35 11-05-2015 09-30-2015 10-Q
36 08-04-2015 06-30-2015 10-Q
37 05-06-2015 03-31-2015 10-Q
38 02-27-2015 12-31-2014 10-K
39 11-06-2014 09-30-2014 10-Q
40 08-05-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

goldman-sachs-initiates-coverage-on-abbott-laboratories-with-buy-rating-announces-price-target-of-121
Goldman Sachs Initiates Coverage On Abbott...
05/30/2024 11:39:15

Goldman Sachs analyst David Roman initiates coverage on Abbott Laboratories (NYSE:ABT) with a Buy rating and announces Price...

8-health-care-stocks-whale-activity-in-todays-session
8 Health Care Stocks Whale Activity In Tod...
05/23/2024 17:35:21

critical-insights-from-abbott-laboratories-analyst-ratings-what-you-need-to-know
Critical Insights From Abbott Laboratories...
05/22/2024 18:00:45

citigroup-maintains-buy-on-abbott-laboratories-lowers-price-target-to-119
Citigroup Maintains Buy on Abbott Laborato...
05/22/2024 17:17:57

Citigroup analyst Joanna Wiensch maintains Abbott Laboratories (NYSE:ABT) with a Buy and lowers the price target from $128 t...

jim-cramer-calls-this-healthcare-stock-a-worthy-spec-recommends-avoiding-canada-goose
Jim Cramer Calls This Healthcare Stock A '...
05/21/2024 12:44:12

Cramer recommends staying away from Canada Goose, even though it reported better-than-expected Q4 earnings.

fda-says-abbott-recalls-heartmate-3-left-ventricular-assist-system-implant-kit-for-risk-of-blood-leakage-has-identified-heartmate-3-left-ventricular-assist-system-implant-kit-as-a-class-i-recall-abbott-reports-81-incidents-including-70-injuries-and-two-deaths-related-to-issue
FDA Says Abbott Recalls Heartmate 3 Left V...
05/15/2024 15:13:17

- Reuters

looking-at-abbott-laboratoriess-recent-unusual-options-activity
Looking At Abbott Laboratories's Recent Un...
05/14/2024 17:45:57

amazon-abbott-laboratories-and-2-other-stocks-insiders-are-selling
Amazon, Abbott Laboratories And 2 Other St...
05/09/2024 12:35:58

how-is-the-market-feeling-about-abbott-laboratories
How Is The Market Feeling About Abbott Lab...
05/03/2024 13:15:13

what-the-options-market-tells-us-about-abbott-laboratories
What the Options Market Tells Us About Abb...
05/01/2024 20:46:05

abbotts-receives-fda-approval-for-esprit-btk-everolimus-eluting-resorbable-scaffold-system
Abbott's Receives FDA Approval For Esprit ...
04/29/2024 13:03:19

More than 20 million people in the U.S. are living with peripheral artery disease (PAD) yet there have been limited treatment o...

barclays-maintains-overweight-on-abbott-laboratories-lowers-price-target-to-140
Barclays Maintains Overweight on Abbott La...
04/22/2024 12:36:41

Barclays analyst Matt Miksic maintains Abbott Laboratories (NYSE:ABT) with a Overweight and lowers the price target from $14...

behind-the-scenes-of-abbott-laboratoriess-latest-options-trends
Behind the Scenes of Abbott Laboratories's...
04/18/2024 17:31:58

rbc-capital-maintains-outperform-on-abbott-laboratories-lowers-price-target-to-125
RBC Capital Maintains Outperform on Abbott...
04/18/2024 15:54:14

RBC Capital analyst Shagun Singh maintains Abbott Laboratories (NYSE:ABT) with a Outperform and lowers the price target from...

stocks-fall-as-geopolitics-economic-worries-spook-investors-chipmakers-sell-off-bitcoin-tumbles-to-60000-whats-driving-markets-wednesday
Stocks Fall As Geopolitics, Economic Worri...
04/17/2024 18:09:39

A sentiment of risk aversion looms over the markets during Wednesday’s trading session, triggering midday losses across the boa...

dow-surges-200-points-abbott-laboratories-posts-upbeat-earnings
Dow Surges 200 Points; Abbott Laboratories...
04/17/2024 14:07:53

U.S. stocks traded higher this morning, with the Dow Jones index gaining around 200 points on Wednesday. Following the market ...

abbott-labs-q1-revenue-jumps-on-strong-medical-devices-sales-company-boosts-annual-guidance
Abbott Labs Q1 Revenue Jumps On Strong Med...
04/17/2024 12:42:16

Abbott Laboratories surpasses expectations with Q1 sales hitting $9.96B, a 10.8% rise driven by robust performance in Medical D...

abbott-forecasts-q2-2024-adjusted-eps-of-108-112-versus-consensus-of-112
Abbott Forecasts Q2 2024 Adjusted EPS Of $...
04/17/2024 11:37:50

abbott-revises-2024-adjusted-eps-guidance-to-455-470-versus-prior-guidance-of-450-470-and-consensus-of-462
Abbott Revises 2024 Adjusted EPS Guidance ...
04/17/2024 11:36:44

abbott-laboratories-q1-2024-adj-eps-098-beats-095-estimate-sales-9964b-beat-9880b-estimate
Abbott Laboratories Q1 2024 Adj EPS $0.98 ...
04/17/2024 11:32:10

Abbott Laboratories (NYSE:ABT) reported quarterly earnings of $0.98 per share which beat the analyst consensus estimate of $0.9...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION